Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerAparna R. Parikh, Ryan B. Corcoran, Emily E. Van Seventer et al.|Clinical Cancer Research|2021Cited by 358
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M. Huffman, Samuel J. Klempner, Gregory P. Botta et al.|JCO Precision Oncology|2022Cited by 72
Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitorsJakob M. Riedl, Ryan B. Corcoran, Ferran Fece de la Cruz et al.|Annals of Oncology|2025Cited by 49